|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
11.50(B) |
Last
Volume: |
464,634 |
Avg
Vol: |
475,567 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
1,636 |
31,084 |
49,996 |
92,833 |
Total Sell Value |
$374,194 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
Total People Sold |
2 |
6 |
6 |
8 |
Total Sell Transactions |
2 |
11 |
16 |
28 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Creamer Victoria L |
EVP & Chief People Officer |
|
2022-02-22 |
4 |
D |
$293.61 |
$52,850 |
D/D |
(180) |
9,770 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-02-22 |
4 |
D |
$293.61 |
$84,266 |
D/D |
(287) |
4,084 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2022-02-22 |
4 |
D |
$293.61 |
$80,449 |
D/D |
(274) |
33,949 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2022-02-22 |
4 |
D |
$293.61 |
$14,974 |
D/D |
(51) |
6,094 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-02-22 |
4 |
S |
$290.81 |
$115,170 |
D/D |
(396) |
20,562 |
|
24% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-02-22 |
4 |
D |
$293.61 |
$93,074 |
D/D |
(317) |
20,958 |
|
- |
|
Wallman Richard F |
Director |
|
2022-02-18 |
4 |
S |
$295.00 |
$339,250 |
D/D |
(1,150) |
17,679 |
|
27% |
|
Wallman Richard F |
Director |
|
2022-02-18 |
4 |
S |
$297.50 |
$833,000 |
I/I |
(2,800) |
3,250 |
|
27% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-02-18 |
4 |
S |
$291.80 |
$333,527 |
D/D |
(1,143) |
21,275 |
|
27% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-02-18 |
4 |
OE |
$88.05 |
$65,421 |
D/D |
743 |
22,418 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2022-02-15 |
4 |
AS |
$308.23 |
$6,309,137 |
D/D |
(20,000) |
218,402 |
|
-28% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-02-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
21,675 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-02-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
6,178 |
18,090 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-02-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,178 |
4,371 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2022-02-01 |
4 |
D |
$329.76 |
$113,108 |
D/D |
(343) |
9,950 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-01-28 |
4 |
D |
$312.24 |
$1,426,937 |
D/D |
(4,570) |
21,825 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
11,344 |
26,395 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2022-01-28 |
4 |
D |
$312.24 |
$7,839,722 |
D/D |
(25,108) |
238,402 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
65,011 |
263,510 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2022-01-28 |
4 |
D |
$312.24 |
$257,910 |
D/D |
(826) |
6,145 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,741 |
6,971 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2022-01-28 |
4 |
D |
$312.24 |
$747,815 |
D/D |
(2,395) |
10,293 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,302 |
12,688 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-01-28 |
4 |
D |
$312.24 |
$1,278,623 |
D/D |
(4,095) |
10,549 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,273 |
14,644 |
|
- |
|
1166 Records found
|
|
Page 9 of 47 |
|
|